Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-14-005102)

Filing Details

Accession Number:: 0001179110-14-005102
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2014-03-12 17:01:48
Reporting Period:: 2014-03-07

Filing Date:: 2014-03-12
Accepted Time:: 2014-03-12 17:01:48
Original Submission Date:: 2014-03-11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
821995	Columbia Laboratories Inc	CBRX	Pharmaceutical Preparations (2834)	592758596

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1496606	Coventry Acquisition, Llc	C/O Actavis Chief Legal Counsel Morris Corp Ctr Iii, 400 Interpace Pkwy Parsippany NJ 07054		No	No	Yes	No
1578845	Plc Actavis	C/O Actavis Chief Legal Officer Morris Corp Ctr Iii, 400 Interpace Pkwy Parsippany NJ 07054		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-03-07	1,400,000	$6.08	0	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote

Footnotes

The shares reported herein reflect the 1-for-8 reverse stock split of the Issuer's common stock which took effect on August 9, 2013.
Coventry Acquisition LLC, the direct record holder of the shares reported herein, is an indirect subsidiary of Actavis plc.
This amendment to Form 4 is being filed solely to correct the price per share amount in Column 4 from $5.76 to $6.0779.